We are live on ! Find out more
PFA

Pathway Financial Advisers Portfolio holdings

AUM $397M
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-4.06%
1 Year Est. Return
+33.93%
3 Year Est. Return
+82.41%
5 Year Est. Return
10 Year Est. Return
AUM
$242M
AUM Growth
Cap. Flow
+$253M
Cap. Flow %
104.51%
Top 10 Hldgs %
21.5%
Holding
479
New
479
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$6.89M
2
PEP icon
PepsiCo
PEP
+$5.99M
3
JPM icon
JPMorgan Chase
JPM
+$5.46M
4
DUK icon
Duke Energy
DUK
+$5.34M
5
STLD icon
Steel Dynamics
STLD
+$5.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 12.35%
2 Healthcare 11.67%
3 Technology 11.65%
4 Financials 11.18%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$177B
$2.89M 1.19%
+10,953
New +$3.12M
OHI icon
27
Omega Healthcare
OHI
$14.2B
$2.87M 1.19%
+86,602
New +$2.77M
MDT icon
28
Medtronic
MDT
$119B
$2.83M 1.17%
+36,159
New +$3.03M
SCHD icon
29
Schwab US Dividend Equity ETF
SCHD
$110B
$2.63M 1.09%
+111,678
New +$2.74M
UPS icon
30
United Parcel Service
UPS
$84.4B
$2.54M 1.05%
+16,307
New +$2.81M
WM icon
31
Waste Management
WM
$84.8B
$2.4M 0.99%
+15,721
New +$2.54M
APD icon
32
Air Products & Chemicals
APD
$62.7B
$2.38M 0.98%
+8,385
New +$2.46M
PDT
33
John Hancock Premium Dividend Fund
PDT
$595M
$2.28M 0.94%
+236,850
New +$2.51M
VIG icon
34
Vanguard Dividend Appreciation ETF
VIG
$110B
$2.24M 0.93%
+14,432
New +$2.34M
PM icon
35
Philip Morris
PM
$297B
$2.23M 0.92%
+24,067
New +$2.32M
CVS icon
36
CVS Health
CVS
$113B
$2.22M 0.92%
+31,742
New +$2.25M
VICI icon
37
VICI Properties
VICI
$26.4B
$2.16M 0.89%
+74,388
New +$2.31M
WLKP icon
38
Westlake Chemical Partners
WLKP
$752M
$2.13M 0.88%
+98,048
New +$2.19M
KO icon
39
Coca-Cola
KO
$378B
$1.97M 0.81%
+35,109
New +$2.11M
MRK icon
40
Merck
MRK
$361B
$1.89M 0.78%
+18,345
New +$1.98M
CMI icon
41
Cummins
CMI
$72.7B
$1.87M 0.77%
+8,176
New +$1.97M
WPC icon
42
W.P. Carey
WPC
$15.2B
$1.85M 0.77%
+35,003
New +$2.24M
BIP icon
43
Brookfield Infrastructure Partners
BIP
$16.4B
$1.85M 0.76%
+62,852
New +$2.08M
BMY icon
44
Bristol-Myers Squibb
BMY
$128B
$1.84M 0.76%
+31,640
New +$1.94M
BCE icon
45
BCE
BCE
$20.6B
$1.83M 0.76%
+47,937
New +$2.01M
PFE icon
46
Pfizer
PFE
$157B
$1.83M 0.76%
+55,157
New +$1.95M
EMR icon
47
Emerson Electric
EMR
$82.9B
$1.79M 0.74%
+18,538
New +$1.77M
HD icon
48
Home Depot
HD
$300B
$1.75M 0.72%
+5,790
New +$1.86M
MET icon
49
MetLife
MET
$61.7B
$1.75M 0.72%
+27,785
New +$1.73M
UL icon
50
Unilever
UL
$133B
$1.69M 0.7%
+30,395
New +$1.76M

Similar funds

Pathway Financial Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Pathway Financial Advisers held 479 positions worth $242M. Its ten largest holdings account for 21% of the portfolio.

Pathway Financial Advisers deployed $253M of net new capital in Q3 2023, opening 479 new positions. Its largest new stake was Enterprise Products Partners: 257,464 shares worth $7.05M.

By sector, the portfolio is most concentrated in Miscellaneous at 12% of assets, followed by Healthcare and Technology.

  • Pathway Financial Advisers's largest Q3 2023 buy was Enterprise Products Partners: 257,464 shares worth $7.05M.
  • Pathway Financial Advisers's ten largest holdings make up 21% of its $242M portfolio in Q3 2023.
  • Pathway Financial Advisers opened 479 new positions and closed 0 in Q3 2023.

Based on Pathway Financial Advisers's 13F filing for Q3 2023, filed 19 Jul 2024.